Access to the PDF text

Free Article !

Archives of cardiovascular diseases
Volume 102, n° S1
page 19 (mars 2009)
Doi : 10.1016/S1875-2136(09)72168-0
Themes et posters

A035 TSP1 mediates echinocytosis and contributes to vaso-occlusive crises in sickle cell disease

S. Camus 1, P. Eren 1, D. Francois 1, P. Bonnin 2, R. Kokode 3, M. Hoylaerts 4, A. Tedgui 1, P. Tharaux 1, O. Blanc-Brude 1
1 Centre de Recherche Cardiovasculaire Inserm-Lariboisière, U689, Hôpital Lariboisière, Paris, France 
2 Service de Physiologie-Explorations Fonctionnelles et Inserm U965, Hôpital Lariboisière, Paris, France 
3 Service d’Hématologie, Hôpital Kremlin-Bicêtre, Paris, France 
4 Université Catholique de Louvain, Louvain, Belgium 


In sickle cell disease (SCD), the expression of mutated hemoglobin allows the formation of rigid, sickle-shaped and dense red blood cell (RBC). In patients, hypoxia, exercise or cold lead to vaso-occlusive crisis (VOC), with hypoperfusion in microcirculatory beds occluded by sickled, dense erythrocytes, causing ischemic tissue injury with intense pain. The renal medulla has substantial metabolic activity, with high oxygen demand, hyperosmolarity and low pH. Kidneys are thus particularly vulnerable to hypoxia and acute VOC. Platelet TSP1 released during thrombosis, and its RBC surface receptor CD47 have previously been involved in increased adhesion of RBC to endothelium in SCD. Here, we investigated other effects of TSP1 and CD47 on RBC in connection with VOC. We used SAD transgenic mice expressing mutated human hemoglobin (⍺2β2SAD). We found that circulating TSP1 levels increased 4 fold in SAD mice under hypoxia (8 % O2) for 16hours, whereas TSP1 levels were strongly depressed in wild type mice (−70 %). Electron microscopy and ektacytometry revealed that TSP1-derived CD47 agonist peptides in synergy with hypoxia triggered RBC echinocytosis in healthy RBC (+600 %). Wild type echinocytes however conserved constant numbers of short round spicules. SAD RBC also responded with increased echinocytosis (+100 %), coupled to a doubling in the aberrantly rigid, fine and elongated spicules they carried, compared to normoxia. No true sickling was observed. Intravenous injection of CD47 agonist to anesthetized wild type mice significantly reduced renal blood flow by 17 %, as assessed by echo-Doppler, indicating increased renal microvascular resistance. Renal blood flow returned to normal values within 5minutes. In contrast, administration of CD47 agonist peptides to SAD mice reduced renal blood flow by 48 %, for more than 20minutes. Mutated control peptides had no effects, and we observed no significant modulation of heart beat rates, or cardiac output. We concluded that the release of TSP1 may synergize with hypoxia to mediate echinocytosis and contribute to lasting vasoocclusive crises.

The full text of this article is available in PDF format.
The full text of this article is available in PDF format.
Click here to see it.

Top of the page

© 2009  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline